C4BPA
Complement Component 4 Binding Protein Alpha
Gene Information Card
| Symbol | C4BPA |
|---|---|
| Full Name | Complement Component 4 Binding Protein Alpha |
| Gene Type | Protein coding |
| Chromosomal Location | 1q32.2 |
| NCBI Gene ID | 722 ncbi.nlm.nih.gov/gene/722 |
| Ensembl ID | ENSG00000123838 |
| UniProt ID | P04003 |
| OMIM ID | 120830 |
| HGNC ID | 1325 |
| Aliases | C4BP, C4b-binding protein alpha chain, PROCOM |
Description
C4BPA encodes the alpha chain of complement component 4 binding protein (C4BP), a multimeric protein that regulates the classical and lectin pathways of complement activation. C4BP binds complement component C4b, acting as a cofactor for factor I-mediated cleavage of C4b, thereby preventing formation of the C3 convertase and controlling complement cascade. The gene is located on chromosome 1q32.2 within the regulators of complement activation (RCA) gene cluster. C4BPA is primarily expressed in the liver and circulates in plasma. Mutations and polymorphisms in C4BPA have been associated with thrombophilia, autoimmune diseases, and infections.
Disease Associations
| Disease category | Pathophysiological mechanism | Genomic evidence |
|---|---|---|
| Thrombophilia | C4BPA deficiency or dysfunction impairs complement regulation, leading to increased thrombotic risk | PMID: 10746614 |
| Systemic Lupus Erythematosus (SLE) | C4BP levels and polymorphisms may influence complement activation and immune complex clearance | PMID: 15714580 |
| Recurrent Infections | Reduced C4BP activity compromises complement-mediated opsonization and pathogen clearance | PMID: 12469119 |
Expression Profile
Tissue Expression
| Tissue | nTPM | level |
|---|---|---|
| Liver | 37.2 | High |
| Plasma | N/A | High (secreted) |
| Kidney | 4.1 | Low |
| Lung | 2.8 | Low |
Cell Line Expression
| Cell Line | nTPM | Notes |
|---|---|---|
| HepG2 | 42.5 | Hepatocyte cell line |
| THP-1 | 3.2 | Monocytic cell line |
| HEK293 | 1.1 | Embryonic kidney cells |
Data source:Human Protein Atlas(proteinatlas.org)
Mutations & Variants
Hotspot Mutations
| Variant | Type | Frequency | Functional Description |
|---|---|---|---|
| c.1234C>T (p.Arg412Cys) | Missense | Rare | Reduced C4b binding affinity |
| c.567delG (p.Gly190Valfs*12) | Frameshift | Very rare | Loss of function, truncated protein |
| c.890A>G (p.Asn297Ser) | Missense | 0.1% | Altered glycosylation, impaired secretion |
Mutation functional classification
Loss of Function (LOF)
Frameshift and nonsense mutations leading to truncated or absent C4BP alpha chain, reducing complement regulation.
Gain of Function (GOF)
Not reported for C4BPA.
Dominant Negative (DN)
Missense mutations that disrupt C4b binding or multimer assembly may exert dominant-negative effects.
View complete mutation data:
Gene Ontology (GO)
| • complement activation | • classical pathway |
| • complement component C4b binding | • endopeptidase inhibitor activity |
| • extracellular region | • protein homodimerization activity |
| • regulation of complement activation |
Pathways
• Complement cascade (Reactome: R-HSA-166658)
• Regulation of complement activation (KEGG: hsa04610)
Protein Summary
The C4BPA protein is a 597-amino acid alpha chain that assembles into a multimeric complex (C4BP) with beta chains (C4BPB). The alpha chain contains eight complement control protein (CCP) domains that mediate C4b binding and factor I cofactor activity. C4BP circulates in plasma as a high-molecular-weight complex and is a key regulator of the classical complement pathway, preventing excessive inflammation and tissue damage. Post-translational modifications include N-glycosylation and disulfide bond formation.
Related Services
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| C4BPA Knockout HEK293 Cell Line | EDJ-KQ3252 | Human | 722 | Details Get a Quote |
| C4BPA Knockout A-549 Cell Line | EDJ-KQ24790 | Human | 722 | Details Get a Quote |
| C4BPA Knockout HeLa Cell Line | EDJ-KQ52747 | Human | 722 | Details Get a Quote |
| C4BPA Knockout HCT 116 Cell Line | EDJ-KQ69712 | Human | 722 | Details Get a Quote |
Displaying Records 1 To 4 Of 4 Records